Johnson & Johnson is one of the largest medical and consumer goods companies in the world. It is more than 100 years old and develops various pharmaceuticals, medical devices, and consumer packaged goods. The company ranks highly in the Fortune 500 list and is also considered one of the world’s most valuable companies. Healthcare has been the flavour of the day during the pandemic, and there are many health care stocks for 2021 that investors can choose from. Investors can look at medical devices, pharmaceuticals, innovation-focused companies, healthcare REITs, hospital operators, insurance companies, etc. Johnson & Johnson has operations in multiple sub-sectors of the healthcare industry. The company can potentially be a pick for investors looking to take positions in the healthcare industry.
Johnson & Johnson Business Background
Johnson & Johnson was founded back in 1886. The company’s founders are Robert Wood Johnson, James Wood Johnson, and Edward Mead Johnson. Robert Johnson had a background in pharmaceuticals. The company began operations selling surgical supplies, medical guides, and other household products. Over the years, Johnson & Johnson expanded into a diversified company that has 250 subsidiaries and does business in 175 countries. The company has a physical presence in 60 countries. Some of the most well-known products of Johnson & Johnson include Band-Aid and Tylenol. Johnson’s baby products are also quite popular in multiple countries around the world. The company crossed annual revenues of $100 billion in 2019. It is among the top health care stock picks with a credit rating of AAA.
Johnson & Johnson’s stock closed at $170 on 24th May 2021. The stock was trading at a dividend yield of 2.5% at the time. Johnson & Johnson had risen by close to 18% over the preceding year. The 1-month return for the stock was 3.9%.